Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Iovance Biotherapeutics (IOVA) Assets Average: 2011-2025

Historic Assets Average for Iovance Biotherapeutics (IOVA) over the last 7 years, with Sep 2025 value amounting to $906.2 million.

  • Iovance Biotherapeutics' Assets Average was N/A to $906.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $906.2 million, marking a year-over-year change of. This contributed to the annual value of $845.4 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Iovance Biotherapeutics' Assets Average is $906.2 million, which was down 3.30% from $937.1 million recorded in Q2 2025.
  • In the past 5 years, Iovance Biotherapeutics' Assets Average registered a high of $938.6 million during Q1 2025, and its lowest value of $610.3 million during Q1 2023.
  • Its 3-year average for Assets Average is $828.7 million, with a median of $820.7 million in 2023.
  • Data for Iovance Biotherapeutics' Assets Average shows a peak YoY surged of 35.20% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Assets Average (Quarterly) stood at $816.3 million in 2023, then skyrocketed by 35.20% to $825.1 million in 2024, then climbed by 13.76% to $906.2 million in 2025.
  • Its last three reported values are $906.2 million in Q3 2025, $937.1 million for Q2 2025, and $938.6 million during Q1 2025.